Lb Pharmaceuticals (LBRX) Debt Ratio (2024 - 2026)

Lb Pharmaceuticals has reported Debt Ratio for 3 years, with the latest figure at 0.0 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Mar 2026 stood at 0.0 (changed N/A YoY), and the FY2025 full-year result was 0.0, down 94.25% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.0, down from 0.0 in the prior quarter.
• The five-year high for Debt Ratio was 0.07 in Q4 2024, with the low at 0.0 in Q1 2026.
• Average Debt Ratio over 3 years is 0.02, with a median of 0.0 recorded in 2025.
• Peak annual rise in Debt Ratio reached 94.25% in 2025, while the deepest fall reached 94.25% in 2025.
• Tracing LBRX's Debt Ratio over 3 years: stood at 0.07 in 2024, then slumped by 94.25% to 0.0 in 2025, then slumped by 32.31% to 0.0 in 2026.
• The last three Debt Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.

Peer Comparison